Fierce Pharma
FEBRUARY 2, 2023
Amid mainstream hype, Eli Lilly takes a hard line marketing its buzzy diabetes med Mounjaro fkansteiner Thu, 02/02/2023 - 11:20
PharmaTech
FEBRUARY 2, 2023
The COVID-19 pandemic has led to many changes and shifts in the pharmaceutical industry, specifically with how pharmaceutical companies develop vaccines.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
FEBRUARY 2, 2023
Fierce Pharma Asia—J&J, Legend's CAR-T win; Sanofi's India job cuts; BeiGene, Novartis' PD-1 delay aliu Thu, 02/02/2023 - 15:58
Legacy MEDSearch
FEBRUARY 2, 2023
Tyber Medical LLC has acquired 100 percent of the capital of ADSM-Synchro Medical, a French orthopedic medical device company, specializing in the development and distribution of implants dedicated to treating surgical forefoot pathologies.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.
.png)
Fierce Pharma
FEBRUARY 2, 2023
Novo's Rybelsus comes into its own as Wegovy shakes off supply constraints fkansteiner Thu, 02/02/2023 - 08:57
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Fierce Pharma
FEBRUARY 2, 2023
Roche taps insider Graham for top pharma job as setbacks prompt M&A questions aliu Thu, 02/02/2023 - 10:46
PharmaVoice
FEBRUARY 2, 2023
The FTC and DOJ are heightening antitrust enforcement, and pharma deals are a prime target
Fierce Pharma
FEBRUARY 2, 2023
Bristol Myers holds on to blockbuster Sotyktu hopes, plays down Otelza threat zbecker Thu, 02/02/2023 - 13:22
PharmaTech
FEBRUARY 2, 2023
Shifting guidance and the growing prominence of computer software assurance exemplify the state of computer software validation.
Storyvine
FEBRUARY 2, 2023
ASCO is a great opportunity to reconnect with colleagues, show off your brand and discover what’s new in cutting edge oncology research. Storyvine wants to help you make the most of it.
Fierce Pharma
FEBRUARY 2, 2023
How AbCellera helps partners propel their antibody therapies to the clinic jpiatt Thu, 02/02/2023 - 10:34
Pharma Pathway
FEBRUARY 2, 2023
Mankind Pharma Limited- Openings for AGL/ GL -API Technology Transfer -Apply Now Job Description Openings for AGL/ GL -API Technology Transfer Department @ Mankind Pharma Limited Department: AGL/ GL -API Technology Transfer Qualification : B.Tech/ B.E/
Fierce Pharma
FEBRUARY 2, 2023
Merck's recent Keytruda label expansion in NSCLC is more of a 'long-term' opportunity, CEO says kdunleavy Thu, 02/02/2023 - 10:43
Pharma Pathway
FEBRUARY 2, 2023
Hetero Labs Limited-Walk-In Interviews for Freshers in Quality Control/ Quality Assurance/ Production On 5th Feb’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”.
MedCity News
FEBRUARY 2, 2023
More than 90% of nurses in Michigan believe that understaffing is negatively affecting the quality of care they’re able to provide, according to a new report.
Pharma Pathway
FEBRUARY 2, 2023
Aurobindo Pharma-Walk-In Interviews for Packing Department On 4th Feb’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceutical manufacturing firm with turnover of over US$2.8
MedCity News
FEBRUARY 2, 2023
Under the proposed new rule, employers are no longer able to be exempt from covering contraception due to moral convictions, but religious exemptions still remain. It’s an important move from the government during the reproductive health crisis, one advocate said.
Pharma Pathway
FEBRUARY 2, 2023
Hy-Gro Chemicals Pharmtek Pvt. Walk-In Interviews for R&D On 4th Feb’ 2023 Job Description Hy-Gro Chemical Pharmtek Pvt.
MedCity News
FEBRUARY 2, 2023
There were more than 35 million prior authorization requests submitted to MA plans in 2021, and 2 million were denied, according to KFF. Of those denied, just 11% were appealed. However, most of those appeals led to the denial being overturned.
Pharmaceutical Technology
FEBRUARY 2, 2023
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline ’s (GSK) Jesduvroq (daprodustat) to treat anaemia caused by chronic kidney disease (CKD) in adults who have been on dialysis for at least four months.
MedCity News
FEBRUARY 2, 2023
New York healthcare startups received $3.9 billion of funding in 2022, compared to $9 billion in 2021, according to a new DHNY report. Biotech startups represented 22% of total funding in 2022, a stark difference from women’s health only representing 2%.
Pharmaceutical Technology
FEBRUARY 2, 2023
If things go as per plan, in a few months, the US Food and Drug Administration (FDA) will deliberate on the first-of-its-kind CRISPR-based gene therapy for sickle cell disease (SCD) and transfusion-dependent beta thalassemia.
MedCity News
FEBRUARY 2, 2023
The FDA approved GSK drug Jesduvroq for treating anemia in patients with chronic kidney disease. The once-daily pill is the first oral medicine to pass FDA muster in this indication, giving patients a more convenient alternative to injectable anemia therapies.
Copyright Clearance Center
FEBRUARY 2, 2023
The post Workflow of the Future: Standards & Sustainability Part II appeared first on Copyright Clearance Center. CCC in the News
MedCity News
FEBRUARY 2, 2023
Carolyn Bertozzi, Barry Sharpless, and Morten Meldal shared the 2022 Nobel Prize in Chemistry for greatly simplifying the synthesis of complicated molecules. Dr. Bertozzi’s protégé writes why her research is so important. BioPharma Daily MedCity Influencers SYN Top Story biopharma nl oncology
Pharma Pathway
FEBRUARY 2, 2023
Micro Labs-Walk-In Interviews for B. Pharma/ M.Pharm/ B.Sc/ M.Sc in QA/ QC On 4th Feb’ 2023 Job Description Walk-In Interviews for B. Pharma/ M.Pharm/ B.Sc/ M.Sc in QA/ QC On 4th Feb’ 2023 @ Micro Labs Departments: QA/ QC Qualification: B. Pharma, M.Pharm, B.Sc, MS/ M.Sc
MedCity News
FEBRUARY 2, 2023
Protectionism against (and fear of) telehealth on display from companies like Walmart and states like Alabama threaten the only effective and scalable solution to America’s opioid epidemic. Daily Health Tech Legal MedCity Influencers Physicians SYN Top Story opioid crisis Opioid use disorder
PharmaTimes
FEBRUARY 2, 2023
The central focus of the agreement is to establish peptide hits from selected library populations
MedCity News
FEBRUARY 2, 2023
Two Congresspeople recently introduced a bill seeking to terminate the VA’s Oracle Cerner EHR rollout. The legislation said that the project is too flawed and costly to carry on — the lawmakers called for VA facilities to revert back to the department’s internally developed EHR.
European Pharmaceutical Review
FEBRUARY 2, 2023
While maintaining a healthy manufacturing industry for production of ‘high tech’ pharmaceuticals, Europe has stepped away from manufacturing essential medicines and active pharmaceutical ingredients (APIs) due to unrelenting price pressures and is now heavily reliant on the import of these critical ingredients.
MedCity News
FEBRUARY 2, 2023
Karuna Therapeutics has licensed two small molecules that shuttering Goldfinch Bio had developed for kidney disorders.
PharmaTimes
FEBRUARY 2, 2023
Boost concerns rapid deployment of novel detection reagents for testing in low to middle-income countries
Pharma Pathway
FEBRUARY 2, 2023
Natco Pharma Limited -Walk-In Interview for Formulation Research & Development (OSD & Injectable) On 4th Feb’ 2023 Job Description Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulation (“FDF”) and active pharmaceutical ingredients (“APIs”). Our focus is primarily on niche therapeutic areas and complex products.
Expert insights. Personalized for you.
246 
Let's personalize your content